Observational studies have generally shown a lesser risk of HF at lower glycaemic levels. However, few population-based real-world studies have evaluated the importance of glycaemic control on the development of HF beginning at diagnosis of T2D, and contemporary estimates are sparse. Recently, we found that the estimates of glycaemic control in relation to myocardial infarction varied over time with less strong associations during more recent time periods